Cameron Health Inc.
This article was originally published in Start Up
Cameron Health believes that the market for implantable cardiac defibrillators (ICDs) is underpenetrated because of the complexity involved in implanting and programming current devices. The company's cardiologist founders created an implantable device that effectively terminates ventricular defibrillation, without using leads that contact the heart directly. Heart leads are the weakest link of current devices, since they can break, become dislodged, or incur infection, Cameron's Health device, which can be implanted subcutaneously in a ten minute procedure should help electrophysiologists handle a higher volume of patients and enable cardiologists to get a share of the procedures as well.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.